“…It increased the apoptosis of leukemic cell lines by inducing demethylation and the transcriptional activation of pro-apoptotic proteins. [86] In vitro: KG-1 cells Improved the efficacy of TRAIL in apoptosis induction by upregulating the expression of DR4 and DR5 and downregulating several antiapoptotic proteins like XIAP, c-IAP1 and c-IAP2. [87] AML, acute myeloid leukemia; APL, acute promyelocytic leukemia; ATRA, all-trans retinoic acid; ERβ, estrogen receptor beta; TNFα, tumor necrosis factor alpha; mTOR, mammalian target of rapamycin; FLT3, fms like tyrosine kinase 3; ANXA1, Annexin A1; 2-DG, 2-deoxy-D-glucose; ERK, extracellular signal-regulated kinase; DNMT, DNA methyltransferase; HDAC, histone deacetylase; ROS, reactive oxygen species; TRAIL, TNF-related apoptosis-inducing ligand; DR, death receptor; XIAP, X-linked inhibitor of apoptosis protein; c-IAP, cellular inhibitor of apoptosis.…”